A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/122 (2006.01) A61K 31/00 (2006.01) A61K 31/015 (2006.01) A61K 31/11 (2006.01) A61K 31/473 (2006.01) A61K 31/66 (2006.01) A61K 31/695 (2006.01) A61P 1/04 (2006.01) A61P 9/10 (2006.01) A61P 11/06 (2006.01) A61P 17/06 (2006.01) A61P 19/02 (2006.01) A61P 37/06 (2006.01)
Patent
CA 2330350
The invention provides therapeutic and biological uses of chemokine-receptor- binding compounds (including chemokine receptor ligands such as chemokine receptor agonists or antagonists), such as tricyclic phenanthrene derivatives, including uses in the treatment of disease states mediated by chemokines. The relevant chemokines may for example be monocyte chemoattractant protein-one (MCP-1) or interleukin- 8 (IL-8), and the relevant chemokine receptors may for example be corresponding chemokine receptors (CCR-2, CCR-4, CXCR-1, and CXCR-2). In other aspects, the invention provides corresponding pharmaceutical compositions and therapeutic methods. In one aspect, for example, the invention provides for the use of phenanthrene-9,10-dione in the treatment of multiple sclerosis. -51-
Liu Jiankai
Salari Hassan
Saxena Geeta
Chemokine Therapeutics Corporation
Liu Jiankai
Salari Hassan
Saxena Geeta
Smart & Biggar
LandOfFree
Therapeutics for chemokine mediated diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutics for chemokine mediated diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutics for chemokine mediated diseases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1775245